Seguir
Teofilo Vasconcelos
Teofilo Vasconcelos
BIAL
Email confirmado em bial.com - Página inicial
Título
Citado por
Citado por
Ano
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
T Vasconcelos, B Sarmento, P Costa
Drug discovery today 12 (23-24), 1068-1075, 2007
20472007
Amorphous solid dispersions: Rational selection of a manufacturing process
T Vasconcelos, S Marques, J das Neves, B Sarmento
Advanced drug delivery reviews 100, 85-101, 2016
3862016
Gellan gum/pectin beads are safe and efficient for the targeted colonic delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, SP Campana-Filho, A Almeida, ...
Polymers 10 (1), 50, 2018
482018
Measuring the emulsification dynamics and stability of self-emulsifying drug delivery systems
T Vasconcelos, S Marques, B Sarmento
European Journal of Pharmaceutics and Biopharmaceutics 123, 1-8, 2018
432018
Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
T Vasconcelos, F Araujo, C Lopes, A Loureiro, J das Neves, S Marques, ...
European journal of pharmaceutical sciences 137, 105011, 2019
402019
Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol
FG Prezotti, FI Boni, NN Ferreira, DS Silva, A Almeida, T Vasconcelos, ...
Drug Development and Industrial Pharmacy 46 (2), 236-245, 2020
392020
Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol
T Vasconcelos, F Prezotti, F Araújo, C Lopes, A Loureiro, S Marques, ...
International Journal of Pharmaceutics 595, 120245, 2021
382021
Development of a rapid dissolving ibuprofen solid dispersion
T Vasconcelos, P Costa
Pharm Res 16, 676-681, 2007
372007
The biopharmaceutical classification system of excipients
Vasconcelos, Teofilo, S Marques, bruno Sarmento
Therapeutic delivery 8 (2), 65-78, 2017
352017
Pharmaceutical composition for poorly soluble drugs
TC De Vasconcelos
US Patent App. 12/920,025, 2011
212011
Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers
C Fontes-Ribeiro, T Macedo, T Nunes, C Neta, T Vasconcelos, ...
Drugs in R & D 9, 447-454, 2008
182008
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 9,132,094, 2015
132015
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
TC de Vasconcelos, RJDS Lima, PMDC Barrocas, LS de Castro Pereira, ...
132010
Polymer-based delivery systems for oral delivery of peptides and proteins
B Sarmento, D Ferreira, T Vasconcelos
Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic …, 2009
132009
Bioequivalence of final tablet formulation and research tablet formulation of eslicarbazepine acetate in healthy volunteers
R Lima, T Vasconcelos, R Cerdeira, M Lefebvre, E Sicard
J Bioequiv Availab 1 (3), 93-98, 2009
112009
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
9*2013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Pharmaceutical composition comprising licarbazepine acetate
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent 8,372,431, 2013
82013
Composition
TC de Vasconcelos, RJ dos Santos Lima, RC de Campos Costa
US Patent App. 12/257,240, 2009
82009
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20